Oncological drug PolEpi and perfusion fluid that allows for longer storage of organs intended for transplantation
NanoGroup has raised €637k across 1 funding round, most recently a round in Oct 2022. Based in Warsaw, Poland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-31 | Other | €637k |
| — |
| View deal → |
